CYP17A1 and Androgen-Receptor Expression in Prostate Carcinoma Tissues and Cancer Cell Lines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
CYP17A1 and Androgen-Receptor Expression in Prostate Carcinoma Tissues and Cancer Cell Lines ; volume:13 ; number:3 ; year:2019 ; pages:157-165
Current urology ; 13, Heft 3 (2019), 157-165
- Creator
-
Giatromanolaki, Alexandra
Fasoulaki, Virginia
Kalamida, Dimitra
Mitrakas, Achilleas
Kakouratos, Christos
Lialiaris, Theodoros
Koukourakis, Michael I.
- DOI
-
10.1159/000499276
- URN
-
urn:nbn:de:101:1-2019112723132782956355
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giatromanolaki, Alexandra
- Fasoulaki, Virginia
- Kalamida, Dimitra
- Mitrakas, Achilleas
- Kakouratos, Christos
- Lialiaris, Theodoros
- Koukourakis, Michael I.
Other Objects (12)
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines
Transcriptome analysis of androgen-induced cellular senescence in prostate cancer cell lines
Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
Independence of HIF1a and androgen signaling pathways in prostate cancer
Lncap-AI prostate cancer cell line establishment by Flutamide and androgen-free environment to promote cell adherent
Androgen receptor profiling predicts prostate cancer outcome
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
Second generation androgen receptor antagonists and challenges in prostate cancer treatment
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines
Transcriptome analysis of androgen-induced cellular senescence in prostate cancer cell lines
Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
Independence of HIF1a and androgen signaling pathways in prostate cancer
Lncap-AI prostate cancer cell line establishment by Flutamide and androgen-free environment to promote cell adherent
Androgen receptor profiling predicts prostate cancer outcome
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
Second generation androgen receptor antagonists and challenges in prostate cancer treatment
Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines
Transcriptome analysis of androgen-induced cellular senescence in prostate cancer cell lines
Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
Independence of HIF1a and androgen signaling pathways in prostate cancer
Lncap-AI prostate cancer cell line establishment by Flutamide and androgen-free environment to promote cell adherent
Androgen receptor profiling predicts prostate cancer outcome
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
Second generation androgen receptor antagonists and challenges in prostate cancer treatment